Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Drops By 62.6%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 10,400 shares, a decrease of 62.6% from the December 31st total of 27,800 shares. Based on an average daily trading volume, of 273,300 shares, the days-to-cover ratio is currently 0.0 days.

Biodexa Pharmaceuticals Price Performance

Biodexa Pharmaceuticals stock opened at $4.29 on Wednesday. Biodexa Pharmaceuticals has a 12 month low of $3.50 and a 12 month high of $74.00. The business has a fifty day simple moving average of $4.49.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.